Epidemiology and Molecular Pathology of Cancer
Semester: J-Term, 2022 TBD
While cancer biology and medical oncology are intimately tied together, the basic science researcher and physician do not always figuratively speak the same language. Many graduate students do not have any experience with medicine or clinical research. This course, which is offered every January, is designed to introduce clinical aspects of cancer to graduate students who perform laboratory-based research, emphasizing the importance of interdisciplinary knowledge. Led by Professor Massimo Loda, chair of the Department of Oncologic Pathology at Dana-Farber Cancer Institute, and Assistant Professor Kathryn Penney, a cancer epidemiologist at the Harvard T.H. Chan School of Public Health, a roster of 20 faculty members instruct students on a variety of topics from advances in molecular diagnostics of lung cancers to environmental risk factors associated with colorectal cancer. Students also gain hands-on experience examining actual patient tissue samples in a live hospital setting and analyzing medical cases with the cooperation of the Department of Pathology at Brigham and Women’s Hospital.
|2020 Syllabus - Epidemiology & Molecular Pathology of Cancer||278 KB|